Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

New security measures for Rag fundraising
2012-01-25

The University of the Free State will no longer allow first-year students to sell Ritsems or to shake their cans for change at traffic robots in Bloemfontein in an effort to raise funds for Rag Community Service.

This decision follows after an evaluation has been done in 2011 and 2012 concerning the safety risk for students during this type of sales at road crossings.
 
The new security measures have specifically been implemented for this type of sales since last year.
 
The measures included, among others, that students should be obliged to wear brightly coloured safety jackets during sales, continuous supervision of first-year students by senior students to ensure that students keep to the rules of the road, and limiting the sales hours at robots.
 
Through notices in the media, an appeal was made on motorists to keep a lookout for students raising money for Rag Community Service. The measures were implemented and the effects thereof for students’ safety during sales at robots monitored since last year. This follows after a student, Ms Hanje Pistorius, was hit by a reckless driver in 2010 and she subsequently lost her leg as a result of the accident. 
 
Although, from all appearances, the new measures are a positive contribution to protect students even more, the UFS decided to abolish the sales and fund-raising actions at traffic robots. As reckless drivers would not necessarily take notice of the extra measures, the risk to students at robots stay unchanged. 
 
"The UFS sets the safety of its students as first priority and considers it in the best interest of students to not expose first-years to the risk during our Rag programme,” says Mr Rudi Buys, Dean: Student Affairs at the UFS.
 
Night fund-raising and the selling of Ritsem in the city’s suburbs will, however, continue. 
 
Although the UFS do not expect the new measures to be detrimental to fund-raising efforts, Rag Community Service currently considers new supporting proposals for the raising of funds for community projects in order to address any possible reduction in funds. 
 
Mr Buys also has an agreement with Ms Pistorius to assist Rag Community Services in the planning of new projects.
 
The Night fund-raising in suburbs will take place on Tuesday 24 January and Thursday 26 January and the UFS calls on residents to assist students and help them in the important task at hand.
 
Three Rag processions will take place on Saturday 28 January 2012. At 10:00 two Rag procession will be leave for Heidedal and Mangaung, where the Kovsie Rag Community Service will hand out food parcels.
 
The main Rag Procession will leave the UFS at 18:00 and will move towards the Old Greys sports ground for the Rag concert with Die Heuwels Fantasties and DJ Black Coffee.

Media Release
25 January 2012
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept